SUMMARY A new stress test for thallium-201 myocardial imaging in which pharmacological coronary vasodilatation with dipyridamole is combined with dynamic exercise is described. In 38 patients with coronary artery disease the sensitivity, total number of defects, degree of redistribution, and visual quality of thallium-201 imaging were greater after dipyridamole with exercise testing than after exercise alone. When the data from these 38 with the new method were compared with standard exercise imaging. The overall sensitivity and specificity of dipyridamole-exercise imaging were assessed in section 2, and in section 3 the optimal time for exercise testing after the large oral dose of dipyridamole was determined by serial measurement of plasma concentrations. 
Thallium-201 myocardial imaging is now an established technique for the diagnosis of coronary artery disease.1 2 Although thallium-201 scintigraphy performed after maximal exercise (exercise imaging) may possess greater sensitivity for coronary disease than does exercise electrocardiography,3 4 false negative scintigrams are still found in about 25% of patients.`While computer assisted quantitation of scintigrams is said to give greater sensitivity than simple visual analysis,8 9 falsely negative results can still be expected when the stress imposed before thallium-201 injection is insufficient to produce regional differences in thallium-201 distribution.
The two widely used stress methods for thallium-201 imaging are dynamic exercise and pharmacological coronary vasodilatation with dipyridamole. 10 The purpose of these studies was to evaluate a simple technique in which maximal exer- cise testing is performed in the presence of a high plasma concentration of dipyridamole (a dipyridamole-exercise stress test). Studies of three groups of patients are described: in section 1 the sensitivity and quality of thallium-201 images obtained
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Accepted for publication 7 January 1986 with the new method were compared with standard exercise imaging. The overall sensitivity and specificity of dipyridamole-exercise imaging were assessed in section 2, and in section 3 the optimal time for exercise testing after the large oral dose of dipyridamole was determined by serial measurement of plasma concentrations. These criteria were designed to select those patients in whom standard thallium-201 imaging could be expected to show a relatively low sensitivity for coronary disease.3 13 By excluding patients with easily induced myocardial ischaemia the probability of angina being produced by dipyridamole alone was also reduced (unpublished observations).
Each Myocardial to background ratio (mean (SD)) 3-44 (057)* 2-99 (0-51)* *p<0-01. We added a further 49 patients who had undergone both dipyridamole-exercise imaging and coronary arteriography not more than six months apart to the 38 patients described in section 1. Exercise electrocardiography in these 49 patients had given a result which was either indeterminate or which had conflicted with the patient's history. All these patients met the first two selection criteria outlined in section 1 and had undergone dipyridamole-exercise imaging either to aid diagnosis or to evaluate the importance of minor coronary stenoses on angiography.
Thallium-201 images were analysed by two experienced observers (PRW and RPHW) using the method described in section 1. 
RESULTS
The scintigraphic and angiographic findings ari summarised in Table 3 Mean dipyridamole concentration reached a peal 60 minutes after ingestion, although values that wer almost as high were measured at 40, 80, 100, and 121 minutes after. At 300 minutes (when the redis tribution images were being recorded) the mea concentration had fallen to 26% of the peak value.
Individually, 11 patients showed evidence a rapid absorption, whereas in three patients absorp tion was apparently much slower with peak value not being reached until after 120 minutes (Fig. 3 e Values are mean (SEM). n n One patient (not included in Fig. 3 19 dipyridamole infrequently caused myocardial ischaemia; in contrast exercise consistently produced angina or ST segment depression or both. In theory the combined stress of dipyridamole and exercise should therefore maximise regional differences in thallium-201 distribution in patients with coronary disease by the differing effects of both interventions on the delivery and extraction of the radionuclide. A second property of dipyridamole is its undisputed ability to produce myocardial ischaemia in patients with coronary disease.'9 2' Although patients with easily induced myocardial ischaemia were excluded from the present study, two patients developed angina after dipyridamole which was severe enough to require reversal by aminophylline.
Five other patients either experienced mild angina after dipyridamole or demonstrated evidence of ischaemia considerably earlier in their exercise test. Two mechanisms may be responsible for the production of ischaemia: firstly, perfusion of the subendocardium may fall when flow across a stenosis of the nutrient artery is increased by, for example, vasodilatation.22 Secondly, dilatation of resistance vessels in well perfused regions may produce steal from regions which are dependent on a collateral circulation.2324 There were 11 patients in whom dipyridamole undoubtedly produced myocardial ischaemia or was essential for the production of an abnormal scintigram; four of seven in whom angiography was performed were shown to have collateral dependent regions of viable myocardium.
The extent to which each of these two properties of dipyridamole was responsible for the improved sensitivity of dipyridamole-exercise imaging is uncertain. If, as seems probable, thallium-201 uptake by the lungs is not significantly affected by dipyridamole,20 then the increased myocardial to background ratio observed with dipyridamoleexercise testing, which was responsible for the improved visual quality of the images, may be presumed to result primarily from increased myocardial blood flow. The finding that in four of the six patients in whom only dipyridamole-exercise imaging was abnormal the myocardial to background ratio was not enhanced suggests, however, that the proWalker, James, Wilde, Wood, Rees duction of ischaemia by dipyridamole must also play an important role.
SENSITIVITY AND SPECIFICITY OF THALLIUM-201 IMAGING
The overall sensitivity for coronary disease of dipyridamole-exercise scintigraphy (the truepositive rate) was 87%; this was 13% better than the sensitivity of the standard exercise imaging. Others have reported a sensitivity of between 67% '9 and 95%8 with exercise imaging and of between 67% '1 and 93%25 with intravenous dipyridamole imaging. The overall sensitivity of exercise imaging was 82% in 1077 patients who had this test from 1976 to 197926; however, these patients were unselected as regards disease severity, and many had previous myocardial infarction. Patient characteristics which tend to increase the sensitivity ofthallium-201 imaging include previous myocardial infarction,27 impaired left ventricular function,'3 severe coronary disease,3 7 and an ineffective collateral circulation28; while the method of image interpretation (visual or quantitative) and the criteria used to define abnormality are also important determinants of sensitivity. In the present studies patients with previous infarction, poor left ventricular function, and severe coronary disease-the correlate of an early positive exercise test29 were excluded; while the criterion for abnormality (that is a > 25% deficiency of thallium-201 activity) was relatively strict and the method of interpretation was visual. Hence in a less carefully selected population and using a more refined method of interpretation an even higher sensitivity could no doubt have been achieved. It should be stressed, however, that any figure quoted for the sensitivity of a test is meaningful only when derived by studying the population in which the test will find clinical application-that is in symptomatic patients with conflicting or indeterminate exercise electrocardiograms.3 56
Dipyridamole-exercise imaging achieved a specificity (true-negative rate) of 92% in 25 33 The absence of redistribution four to six hours after injection is most often due to the presence of a myocardial scar34 but may be seen in an area of viable myocardium whose blood supply is severely compromised. In such instances redistribution may be delayed until 18-24 hours.35 Although in earlier studies the diagnostic value of redistribution was not emphasised data from these studies35 did suggest that "reversible" defects, that is those associated with redistribution, may be more specific indicators of coronary disease than "irreversible" defects. In the present study redistribution was seen in a greater percentage of defects detected after dipyridamole-exercise testing than in those detected after exercise alone. Moreover, all 70 reversible defects produced by dipyridamoleexercise testing were in patients with important coronary disease (predictive value= 100%), whereas three of 29 irreversible defects were in patients with no coronary disease (predictive value=89%). Since the proper selection of patients for dipyridamoleexercise imaging excludes patients with previous myocardial infarction or easily induced ischaemia during exercise or both, a "defect" seen after dipyridamole-exercise testing which shows no redistribution should thus be interpreted with caution.
Only one patient had an abnormal scintigram on exercise testing but not on dipyridamole-exercise testing. This patient's oxygen consumption and the severity of myocardial ischaemia, as judged by maximal heart rate and ST segment depression recorded during exercise, were virtually identical on both occasions. Coronary arteriography showed a single 90% stenosis of the mid-left anterior descending coronary artery and exercise imaging demonstrated (on one projection only) an inferior defect which at four hours showed no redistribution. Since there is a fairly precise correlation between the site of scintigraphic abnormalities and the location of coronary stenosis in patients with single vessel disease,36 both the location and the absence of redistribution cast some doubt on the importance of this defect. In contrast in those four patients in whom only dipyridamole-exercise imaging was abnormal and in whom arteriography was performed, all defects were appropriately situated and demonstrated redistribution.
The safety and low complication rate of this technique, in which two potent stresses are being imposed together on the myocardium, depend on careful patient selection-that is the exclusion of patients with easily induced myocardial ischaemia. There have been no serious complications in the 214 patients who have undergone dipyridamole-exercise Walker, James, Wilde, Wood, Rees thallium-201 imaging. Three per cent of patients had side effects of dipyridamole requiring reversal by aminophylline. These were prolonged angina (two patients), severe headache (two patients), and vomiting (one patient). In only three patients has the exercise phase not been possible.
Patients with coronary disease who have myocardial ischaemia within the first stage of the Bruce protocol have severe disease and a relatively poor prognosis.2937 Unlike patients with symptoms suggestive of ischaemic heart disease but in whom the exercise electrocardiogram is negative or equivocal, diagnosis is not difficult in such patients and they do not require thallium-201 imaging.
Dipyridamole-exercise testing appears to be better than standard exercise testing in terms of sensitivity and quality of thallium-201 imaging. In patients selected on the basis of an inconclusive exercise electrocardiogram the technique is safe, effective, and very simple.
